Dog Allergy Shots: Why the 7-Allergen Complexity Changes Everything
Dog allergy shots (SCIT) face a challenge cat shots don't: seven co-dominant allergens (Can f 1-7) with no single marker exceeding 75% sensitization and no FDA-standardized extract. A 2016 Ann Allergy Asthma Immunol review of 17 trials concluded 'poor and conflicting results.' Critically, Can f 5 — present only in intact male dogs — means some patients are allergic only to male dogs and may tolerate females entirely.
Dog Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to dog — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of dog allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of dog immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of dog extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for dog allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing dog extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription dog immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat dog allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Dog?
The biology, taxonomy, and clinical fingerprint of Dog — the foundation of how SCIT targets it.
Can f 1 is detectable in 94% of all US homes regardless of breed (Nicholas et al., 2011, 173 homes). 'Hypoallergenic' breeds had HIGHER Can f 1 levels than non-hypoallergenic breeds (Vredegoor et al., JACI 2012).
- Scientific name
- Canis lupus familiaris
- Family
- CanidaeDog family
- Type
- Indoor animal dander allergen
- Native to
- Domesticated worldwide; ancestral species Canis lupus (gray wolf) from Eurasia
- Allergen proteins
- Can f 1 (major) — 23-25 kDa lipocalin; 42-75% sensitization; 63% identity with cat Fel d 7Can f 2 — 19-27 kDa lipocalin; 14-33% sensitization; homology with mouse Mus m 1Can f 3 — 67-70 kDa serum albumin; 14-35% sensitization; primary cross-mammalian driverCan f 4 — 16-18 kDa lipocalin; 35-81% sensitization; conformation-dependent IgE bindingCan f 5 — 28 kDa prostatic kallikrein; 33-70% sensitization; produced exclusively by intact male dogsCan f 6 — 27 kDa lipocalin; 38-56% sensitization; 67% identity with cat Fel d 4 and 55% with horse Equ c 1Can f 7 — 14-16 kDa NPC2 protein; 10-20% sensitization; >60% similarity with dust mite Der p 2/Der f 2Can f 8 — cystatin A; ~13% sensitization (Roesner et al., 2022)
- Particle size
- 10-20 μm (dander particles); airborne fraction persists in homes without dogs
- Avoidance difficulty
- Very difficult
How Dog Allergy Presents
Symptoms by body system — useful for distinguishing Dog sensitivity from overlapping allergies and infections.
Respiratory
- Nasal congestion and rhinorrhea triggered by dog contact or entering dog-occupied spaces
- Persistent cough and wheezing in dog-sensitized asthmatic patients
- Perennial rhinitis in households with dogs, compounded by Can f 1 ubiquity in homes without dogs
- Asthma exacerbations associated with concentrated dog allergen exposure (groomers, kennels)
- Occupational asthma in veterinary workers and groomers exposed to high allergen loads
Ocular
- Bilateral conjunctivitis with tearing and itching after dog contact
- Ocular symptoms often milder than with cat allergy in comparative studies
- Periorbital redness and swelling with sustained dog exposure
- Conjunctival response to airborne dog allergen in heavily contaminated environments
Dermal
- Contact urticaria at dog-lick sites — saliva contains Can f 1 and Can f 6
- Hive formation at bite or scratch sites in sensitized individuals
- Flare of atopic dermatitis with chronic dog exposure
- Localized angioedema in highly sensitized patients after direct contact
Systemic
- Fatigue from chronic perennial rhinitis in households with multiple dogs
- Sleep disruption from nocturnal nasal congestion with bedroom dog exposure
- Rarely, anaphylaxis in highly sensitized individuals with concentrated allergen exposure
- In women sensitized to Can f 5 (prostatic kallikrein): cross-reactivity with human PSA may cause human seminal plasma allergy (Mattsson et al., 2009)
I tell dog-allergic patients honestly: the data on dog immunotherapy is not as strong as cat. If we don't know which dog allergen is driving symptoms — Can f 1, Can f 5 in male dogs, or albumin cross-reacting from a previous farm animal exposure — we're guessing. Component testing first, then we decide whether SCIT is the right move or whether the patient is a Can f 5-monosensitized individual who could simply adopt a female dog.
Where Dog Triggers Year-Round
Dog is a perennial trigger — exposure is constant for sensitized patients. Geographic intensity still varies by climate.
12-Month Intensity
Year-roundPerennial: dog allergen is present year-round in homes with dogs. Some increase in outdoor exposure during warmer months with more outdoor dog activity.· Year-round perennial exposure; Can f 1 detectable in 94% of all US homes including those without dogs.
US Exposure Map
20 high-intensity statesWhat Dog Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Dog's seven-allergen profile drives cross-reactivity through two pathways: the lipocalin triad (Can f 6 ↔ Fel d 4 ↔ Equ c 1 connecting dog, cat, and horse) and the serum albumin network (Can f 3 connecting all mammals). Can f 5 shares 55-60% identity with human PSA — a unique cross-reactivity with clinical implications.
Can f 3 ↔ Bos d 6 albumin; Can f 4 ↔ Bos d OBP (37% identity, confirmed cross-reactivity)
Can f 6 ↔ Fel d 4 (67% identity); Can f 1 ↔ Fel d 7 (63% identity); Can f 3 ↔ Fel d 2 albumin
Can f 7 (NPC2 protein) shares >60% similarity with dust mite Der p 2/Der f 2 — an unusual cross-family reactivity
Is SCIT Right for Your Dog Allergy?
Answer five questions to assess how well dog allergy shots might fit your clinical situation — including the critical question of which dog allergen is driving your symptoms.
How severe are your dog allergy symptoms on a day of significant exposure?
The Dog SCIT Protocol
Dog SCIT uses non-FDA-standardized extracts (PNU-based or w/v) — a key difference from cat immunotherapy that contributes to variable clinical outcomes across clinics and manufacturers.
Dose escalation from highly diluted starting concentrations to the maintenance target. Because no FDA-standardized dog extract exists, extract potency can vary between manufacturers and lots. Choosing an extract that includes Can f 5 (absent from many dander-only preparations) is critical for patients sensitized to that allergen. Patients must wait 30 minutes in the clinic after each injection for observation.
Maintenance injections continue for 3-5 years. Symptom improvement during dog SCIT is typically more modest and slower than with cat SCIT, reflecting the complex multi-allergen profile. Realistic patient counseling about moderate rather than dramatic results is appropriate. Comorbid asthma must be well-controlled at each visit.
After completing the full course, your allergist will assess symptom burden and ongoing exposure. Unlike cat SCIT, the durability of dog SCIT response is less well-characterized in the literature. Continued maintenance may be recommended for heavily exposed patients.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Dog SCIT
Dog SCIT efficacy data is substantially weaker than cat or grass SCIT — a 2016 systematic review of 17 clinical trials concluded 'poor and conflicting results,' primarily attributable to extract quality issues and the absence of a clearly dominant allergen.
- Overall improvement in 17-trial review40%Khurana T et al., Ann Allergy Asthma Immunol 2016; systematic review of 17 dog SCIT trials
- Improvement in single-center cohort (dog-sensitized patients)55%Uriarte SA, Sastre J, JIACI 2020; comparative cohort, cat-allergic patients responded better
- Symptom score improvement (Nanda 2004 JACI)48%Nanda A et al., J Allergy Clin Immunol 2004; one of the few SCIT-specific dog trials
Dog SCIT shows moderate and inconsistent efficacy compared to cat or grass immunotherapy. The primary limiting factors are the absence of FDA-standardized extract and the lack of a single dominant allergen comparable to cat's Fel d 1. Patients with confirmed multi-allergen dog sensitization (Can f 1 + Can f 4 + Can f 6) and significant symptom burden may still benefit from SCIT, but realistic expectations of moderate — not dramatic — improvement are appropriate. Component-resolved diagnostics before starting improves the likelihood of targeting the right allergens.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Dog SCIT Side Effects
Dog SCIT side effects follow the general pattern of inhalant allergen immunotherapy. Non-standardized extract may increase unpredictability of local reactions compared to standardized cat extract.
Local reactions
4 documentedSystemic reactions
4 documentedTraditionally dog SCIT was given only in a clinic, but for eligible maintenance patients Curex makes safe at-home self-administration possible: a personalized serum sterile-compounded to USP <797> and lot-tested, a prescribed epinephrine auto-injector confirmed on hand before the first injection, and the first dose plus every dose change supervised live over Zoom by the prescribing allergist; reactions typically begin within ~30 minutes, so a brief post-injection self-observation is advised. Systemic reaction rates with dog extract are comparable to other inhalant allergens, though non-standardized extract creates greater dose unpredictability than with FDA-standardized cat extract.
SCIT vs Alternatives for Dog
Dog-allergic patients have four main treatment options: SCIT (moderate evidence, non-standardized extract), at-home SLIT drops (off-label but evidence-based), avoidance or allergen reduction, and daily antihistamines with nasal steroids.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Moderate — 40-55% improvement in studies | Off-label; evidence extrapolated from cat SLIT | Complete if pet rehomed | Partial — symptoms return when stopped |
| 5-yr cost | $3,500-$10,000 | $129/month | $0 | $500-$2,000/yr |
| Duration | 3-5 years | 3-5 years | Permanent | Indefinite |
| Convenience | Self-administered weekly at home with Curex (build-up) | Daily drops at home | Requires rehoming dog | Daily pills/sprays |
| Safety | Very safe; Curex confirms prescribed epinephrine on hand and supervises your first dose and every dose change live over Zoom | Very safe; no clinic required | No side effects | Generally safe long-term |
| Lasting effect | Some lasting benefit post-course | Ongoing benefit while continuing | Permanent if strict | No lasting effect after stopping |
SCITBest
SLIT
Avoidance
Medications
Dog SCIT is a reasonable option for patients with significant, confirmed multi-allergen dog sensitization who cannot avoid exposure — though patients should expect moderate rather than dramatic improvement given the non-standardized extract and multi-allergen complexity. Curex delivers that same dog immunotherapy as a weekly shot you give yourself at home for $129/month — a personalized serum sterile-compounded to USP <797>, your first dose and every dose change supervised live over Zoom by the prescribing allergist, with a prescribed epinephrine auto-injector confirmed on hand, removing the weekly clinic trips of traditional build-up for eligible patients.
What Dog SCIT Actually Costs
Most major US insurers cover dog SCIT under standard allergy benefits. Non-standardized extract does not typically affect coverage eligibility when prescribed by a board-certified allergist. Out-of-pocket cost depends on deductible, co-insurance, and whether extract preparation and office visits are billed separately. Curex at-home IgE testing identifies specific dog sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your dog allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Dog SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Dog allergy immunotherapy is more challenging than cat for two reasons: the allergen profile and the extract quality. Cat allergy is dominated by a single protein — Fel d 1 — that sensitizes 90-96% of patients and is present in FDA-standardized extracts. Dog allergy involves seven co-dominant allergens (Can f 1-7) with no single marker exceeding 75% sensitization. A 2016 Ann Allergy Asthma Immunol systematic review of 17 dog SCIT trials concluded 'poor and conflicting results,' attributed directly to poor-quality non-standardized extracts and the absence of a clearly dominant allergen. Component-resolved diagnostics before starting SCIT is the best strategy to optimize targeting.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.